Renal effects of levosimendan in patients admitted with acute decompensated heart failure

Trial Profile

Renal effects of levosimendan in patients admitted with acute decompensated heart failure

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Levosimendan (Primary)
  • Indications Decompensated heart failure
  • Focus Pharmacodynamics
  • Most Recent Events

    • 01 Sep 2010 Results presented at the ESC Congress 2010: Annual Congress of the European Society of Cardiology
    • 01 Sep 2010 Status changed from not yet recruiting to active, no longer recruiting.
    • 17 Sep 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top